War­ren Buf­fett gets a dou­ble take as the in­vest­ment pow­er­house set­tles on its first biotech in­vest­ment

Coke. Amer­i­can-Ex­press. Ap­ple. And Bio­gen?

War­ren Buf­fet’s Berk­shire Hath­away, which made it­self in­to a sym­bol of rock-sol­id in­vest­ment strat­e­gy, has re­vealed a stake in the big biotech as it takes on one of the biggest gam­bles in the in­dus­try.

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER